Carregant...
A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
Background. DAS181, a novel host-directed antiviral in development for influenza treatment, was assessed in this phase II clinical trial. Methods. This study was a double-blind, placebo-controlled phase II clinical trial assessing influenza viral load and patient safety in otherwise healthy influenz...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3570175/ https://ncbi.nlm.nih.gov/pubmed/23045618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis622 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|